Comparison of entecavir and lamivudine in preventing HBV reactivation in lymphoma patients undergoing chemotherapy: a meta-analysis

MLA

Zhihui Zhang, et al. “Comparison of Entecavir and Lamivudine in Preventing HBV Reactivation in Lymphoma Patients Undergoing Chemotherapy: A Meta-Analysis.” International Journal of Clinical Pharmacy, vol. 38, no. 5, Dec. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....afd00b19a0f3a3f49ca83c1f0f817fba&authtype=sso&custid=ns315887.

APA

Zhihui Zhang, Huaichao Luo, Pin Shuai, Zhujuan Xiong, Angel Palomino Luis, Meiling Pan, & Sisi Yu. (2015). Comparison of entecavir and lamivudine in preventing HBV reactivation in lymphoma patients undergoing chemotherapy: a meta-analysis. International Journal of Clinical Pharmacy, 38(5).

Chicago

Zhihui Zhang, Huaichao Luo, Pin Shuai, Zhujuan Xiong, Angel Palomino Luis, Meiling Pan, and Sisi Yu. 2015. “Comparison of Entecavir and Lamivudine in Preventing HBV Reactivation in Lymphoma Patients Undergoing Chemotherapy: A Meta-Analysis.” International Journal of Clinical Pharmacy 38 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....afd00b19a0f3a3f49ca83c1f0f817fba&authtype=sso&custid=ns315887.